TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: COVSQ    
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Spike Antibody, Semi-Quantitative, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Aiding in the identification of individuals with an adaptive immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), indicating prior infection or vaccination

 

Manufacture of coronavirus disease 2019 (COVID-19) convalescent plasma

Highlights

This test provides semi-quantitative detection of serum antibodies against the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).

 

This test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection and/or vaccination.

 

Fact sheets for this emergency use authorization (EUA) assay can be found at the following links:

For healthcare providers: www.fda.gov/media/144035/download

For patients: www.fda.gov/media/144036/download

Method Name A short description of the method used to perform the test

Electrochemiluminescence Immunoassay (ECLIA) 

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

SARS-CoV-2 Spike Ab, Semi-Quant, S

Aliases Lists additional common names for a test, as an aid in searching

Coronavirus
Coronavirus Ab
Coronavirus antibody
COVID-19 Ab
COVID-19
COVID-19 antibody
SARS CoV-2 Ab
SARS CoV-2
SARS CoV-2 antibody